
Solifenacin Succinate
Solifenacin Succinate (CAS No: 242478-38-2) is expertly produced at Amber Lifesciences Pvt. Ltd. in GMP-compliant and ISO 9001:2015 certified facilities, ensuring excellent purity, batch uniformity, and alignment with global regulatory standards. Each production lot is supplied with a comprehensive Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), meeting USP/EP pharmacopeial specifications.
Solifenacin Succinate is a muscarinic receptor antagonist primarily used to manage overactive bladder symptoms such as urinary urgency, frequency, and incontinence. It works by selectively inhibiting M3 receptors in the bladder, reducing involuntary muscle contractions. Our API is manufactured under stringent quality assurance protocols and validated processes to ensure superior efficacy and safety in pharmaceutical formulations.
Amber Lifesciences serves pharmaceutical manufacturers, formulation partners, traders,shippers, and distributors across Asia, Europe, the Middle East, and LATAM regions, offering reliable supply chains, technical expertise, and complete regulatory support to accelerate product registration and smooth market entry.
Storage & Transportation
Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from light, moisture, and excessive heat. Follow standard handling procedures during storage and shipping.
CAS No.: | 242478-38-2 |
|---|---|
Synonym: | Solifenacin Vesicare |
Mol. formula: | C27H32N2O6 |
Mol. Weight: | 480.6 g/mol |
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.